YOLFTbeta
Sikarin Public Company Limited

Sikarin Public Company Limited

SKR · BK · Healthcare / Medical Care Facilities

7.95THB+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close7.95
Open8.00
Day Range7.95 – 8.00
52-Week Range6.04 – 8.19
Volume32.80K
Market Cap15.76B
P/E (TTM)25.16
Forward P/E11.31
EPS0.31
Dividend Yield3.33%
Beta0.01
50-Day Avg7.90
200-Day Avg7.42

About

Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. The company operates diabetes and endocrine center, general medicine clinic, emergency and trauma center, surgery clinic, children's dental center, aesthetic center, laboratory department, diagnostic radiology center, CT scan unit, operating rooms, hemodialysis units, physical therapy department with physical medicine and rehabilitation specialist, catheter laboratory, intensive care units, coronary care units, inpatient wards and international wards, after heart and thoracic surgery ward, medical-surgical ward, and pediatric ward. It also operates woman's health center, health center, fertility center, delivery room, nursery department and the inpatient wards, obstetrics and gynecology ward, stroke center, EENT center, international medical center, orthopedics center, and MRI center. In addition, the company is involved in the management of rental spaces; and sale of food and beverages, as well as restaurant and medical clinic business. The company was founded in 1979 and is headquartered in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOLieutenant General Jarax Sangtaweep
  • Employees3.07K
  • Headquarters976 Lasalle Road, Bangkok, Thailand, 10260, Thailand
  • Websitehttps://www.sikarin.com

Leadership

  • Lieutenant General Jarax SangtaweepVice Chairman & CEO · b. 1936
  • Mr. Sanya SarayudhExecutive Vice Chairman · b. 1942
  • Mr. Suriyan KojonrojCOO, Deputy MD, Company Secretary & Director · b. 1980
  • Dr. Atirat Charoonsri M.D.MD & Executive Director · b. 1958
  • Mr. Senee KrajangsriSenior Chief Officer & Executive Director · b. 1964
  • Mr. Sucheep BoonveeraDeputy MD & Executive Director · b. 1960
  • Ms. Paweena ChanchanasoponChief Financial Officer · b. 1982
  • Mr. Surasak SuttamasChief Administrative Officer · b. 1967
  • Dr. Thongchai ChatyingmongkolDeputy Chief Medical Officer

Financials

Income Statement

Currency: THB2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue548.72M618.14M707.58M771.75M821.47M894.89M1.01B1.07B1.20B1.25B1.37B1.44B1.55B1.69B1.86B2.00B2.43B3.15B3.44B3.70B3.87B6.35B5.67B5.82B6.06B6.05B
Growth (%)-+12.65%+14.47%+9.07%+6.44%+8.94%+12.91%+5.79%+12.22%+4.01%+9.42%+5.38%+7.96%+8.53%+10.41%+7.71%+21.46%+29.49%+9.12%+7.64%+4.63%+63.90%-10.69%+2.60%+4.08%-0.19%
Cost of Revenue330.44M393.59M446.03M480.46M505.12M563.38M684.38M716.96M805.50M841.16M905.37M990.79M1.08B1.15B1.32B1.43B1.76B2.30B2.47B2.67B2.74B3.53B3.64B3.82B4.29B4.37B
Gross Profit------326.06M352.03M394.09M406.51M459.87M447.84M475.59M530.89M539.84M569.91M671.68M850.73M967.03M1.03B1.14B2.82B2.04B2.00B1.76B1.67B
Gross Margin------32.27%32.93%32.85%32.58%33.68%31.13%30.62%31.49%29.00%28.43%27.58%26.98%28.11%27.88%29.29%44.39%35.88%34.36%29.09%27.64%
Operating Expense------190.59M198.17M222.33M242.45M272.02M293.97M296.98M341.18M346.90M425.88M435.28M646.47M605.48M670.10M660.95M984.80M706.55M837.84M892.82M733.92M
Operating Income62.11M70.97M74.44M69.80M92.39M81.34M135.47M153.86M171.75M164.06M187.85M153.86M178.61M189.72M192.94M144.03M236.40M204.26M361.56M362.26M474.06M1.83B1.33B1.16B869.12M936.86M
Operating Margin11.32%11.48%10.52%9.04%11.25%9.09%13.41%14.39%14.32%13.15%13.76%10.70%11.50%11.25%10.37%7.18%9.71%6.48%10.51%9.78%12.23%28.88%23.42%19.96%14.35%15.50%
EBITDA------205.81M209.29M252.44M244.05M275.27M252.11M293.47M337.90M346.61M341.02M543.40M589.12M681.69M692.47M869.74M2.28B1.78B1.65B1.43B1.54B
EBITDA Margin------20.37%19.58%21.04%19.56%20.16%17.52%18.89%20.04%18.62%17.01%22.32%18.68%19.81%18.70%22.45%35.94%31.41%28.42%23.58%25.48%
Net Income46.94M65.80M93.77M54.37M96.61M119.96M68.08M73.65M99.93M115.26M142.19M111.32M120.51M148.68M158.07M115.52M189.71M162.71M242.42M242.96M349.68M1.40B1.01B891.07M663.59M751.78M
Net Income Margin8.55%10.65%13.25%7.05%11.76%13.41%6.74%6.89%8.33%9.24%10.41%7.74%7.76%8.82%8.49%5.76%7.79%5.16%7.05%6.56%9.02%21.97%17.84%15.31%10.96%12.44%
Interest Expense00000024.72M22.64M18.60M14.03M15.95M16.89M20.10M23.40M16.20M32.85M66.52M73.86M60.37M58.33M73.52M67.13M47.34M38.58M32.28M30.46M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%2.45%2.12%1.55%1.12%1.17%1.17%1.29%1.39%0.87%1.64%2.73%2.34%1.75%1.57%1.90%1.06%0.83%0.66%0.53%0.50%

Balance Sheet

Currency: THB2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets704.40M646.12M664.84M996.37M951.85M1.09B1.14B1.15B1.20B1.27B1.47B1.59B1.77B2.03B2.79B3.46B5.29B5.35B5.53B5.85B6.47B8.09B8.82B9.25B9.62B9.56B
Total Liabilities775.72M617.01M518.36M598.93M505.85M531.18M512.93M453.61M401.85M400.07M449.13M521.94M633.60M678.32M1.06B1.54B1.81B1.79B1.75B1.97B2.38B2.50B1.92B1.80B1.88B1.65B
Total Equity-29.11M146.49M397.44M446.00M556.96M625.04M698.70M798.53M892.57M1.08B1.13B1.19B1.35B1.73B1.91B3.41B3.49B3.73B3.84B4.04B5.52B6.81B7.35B7.65B7.81B
Cash19.40M45.26M48.32M268.99M69.55M43.04M68.88M63.60M90.63M67.00M59.38M16.85M14.66M30.07M171.60M21.29M56.86M66.88M141.34M198.14M363.75M855.10M842.81M336.48M656.40M784.99M
Total Debt------375.83M308.04M249.25M229.79M281.61M300.96M412.29M390.82M721.50M1.09B1.27B1.26B1.18B1.36B1.74B1.24B966.92M745.96M831.95M609.15M
Net Debt------306.94M244.44M158.62M162.79M222.23M284.11M397.63M360.76M549.89M1.07B1.21B1.20B1.04B1.16B1.37B388.01M124.11M409.49M175.55M-175.84M

Cash Flow

Currency: THB2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow49.21M102.38M115.56M97.47M120.29M114.09M105.46M146.27M206.93M192.19M206.00M224.75M187.83M330.39M210.47M333.36M412.95M533.09M645.17M535.30M717.12M1.60B1.45B1.35B1.43B1.48B
Investing Cash Flow-------105.77M-76.46M-94.53M-101.83M-101.72M-206.65M-215.82M-341.29M-536.12M-532.83M-237.62M-317.77M-310.09M-432.81M-381.99M-496.77M-569.20M-1.13B-739.01M-526.11M
Financing Cash Flow---186.94M-24.81M-12.26M-75.09M-85.37M-114.00M-92.39M-60.64M23.96M28.15M467.19M49.16M-156.02M-205.30M-260.62M-45.69M-169.51M-615.90M-896.41M-728.19M-369.46M-826.88M
Capital Expenditure14.01M20.14M29.29M64.07M154.93M227.93M107.25M74.91M95.66M124.00M119.69M224.17M216.12M347.42M535.22M533.23M237.96M322.08M291.33M451.07M382.77M496.31M538.91M771.78M525.18M355.89M
Free Cash Flow35.20M82.24M86.26M33.40M-34.65M-113.84M-1.78M71.36M111.27M68.19M86.31M585.64K-28.29M-17.02M-324.75M-199.87M174.99M211.01M353.83M84.23M334.35M1.11B914.41M578.64M903.21M1.13B
Dividends Paid---------83.23M83.58M44.98M55.02M69.46M78.04M100.40M86.90M82.35M97.01M137.87M140.65M159.53M410.74M349.49M369.81M410.78M
FCF to OCF71.53%80.33%74.65%34.27%-28.80%-99.78%-1.69%48.79%53.77%35.48%41.90%0.26%-15.06%-5.15%-154.29%-59.96%42.38%39.58%54.84%15.74%46.62%69.06%62.92%42.85%63.23%75.98%
Dividend Paid to FCF---------122.06%96.84%7680.04%-194.44%-407.98%-24.03%-50.23%49.66%39.03%27.42%163.68%42.07%14.40%44.92%60.40%40.94%36.49%

Earnings

Report DateJun 3, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Mar 1, 2017May 12, 2017Aug 30, 2017Nov 29, 2017Feb 21, 2018May 11, 2018Aug 29, 2018Nov 28, 2018Feb 20, 2019May 10, 2019Aug 28, 2019Nov 27, 2019Feb 19, 2020May 15, 2020Sep 2, 2020Dec 2, 2020Feb 24, 2021May 14, 2021Sep 1, 2021Nov 18, 2021Feb 24, 2022May 12, 2022Aug 15, 2022Nov 10, 2022Feb 15, 2023May 11, 2023Aug 11, 2023Nov 14, 2023Feb 22, 2024May 9, 2024Aug 14, 2024Nov 14, 2024Feb 12, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------
EPS Actual0.010.010.030.030.020.020.030.020.030.010.040.030.020.020.020.010.020.010.030.060.010.010.040.030.020.020.050.030.040.010.050.020.040.040.050.050.050.070.170.410.190.080.150.070.100.110.120.100.120.080.120.010.100.100.090.070.060.07
Surprise----------------------------------------------------------
Timing----------------------------------------------------------

Key Statistics & Ratios

Market Cap15.76B
Enterprise Value15.00B
Trailing P/E25.16
Forward P/E11.31
PEG Ratio0.88
Price / Sales2.73
Price / Book2.06
EPS0.31
Book Value3.80
Revenue (TTM)5.77B
Gross Profit (TTM)1.64B
EBITDA1.20B
Profit Margin10.61%
Operating Margin14.18%
Return on Equity7.83%
Return on Assets5.24%
Shares Outstanding2.02B
Shares Float425.88M
Beta0.01
Dividend Yield3.33%
Dividend Rate0.26
Payout Ratio86.41%

Dividends

20262×
0.10Aug 26, 20260.16Apr 29, 2026
20252×
0.09Aug 28, 20250.11Apr 29, 2025
20242×
0.09Aug 28, 20240.09Apr 29, 2024
20232×
0.09Aug 24, 20230.08Apr 26, 2023
20222×
0.08Aug 24, 20220.12Apr 22, 2022
20211×
0.08Apr 29, 2021
20201×
0.07Apr 29, 2020
20191×
0.07Apr 29, 2019
20181×
0.05Mar 22, 2018
20171×
0.04Mar 14, 2017
20161×
0.05Mar 15, 2016
20151×
0.06Mar 24, 2015
20141×
0.05Mar 25, 2014
20131×
0.05Feb 27, 2013
20121×
0.04Mar 26, 2012
20111×
0.03Mar 23, 2011
20101×
0.03Mar 25, 2010
20091×
0.01May 11, 2009
20081×
0.03Dec 29, 2008

Stock Splits

  • May 2, 2018838:831
  • Oct 21, 20161071:1045
  • Sep 29, 2014402:347
  • Sep 9, 19942:1